Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2020 Jun 28;117:108073. doi: 10.1016/j.jsat.2020.108073

Table 2:

Quantile dependent effects from a random intercept repeated measures, quantile regression model analyzing the trend in average daily MMEs among chronic opioid users in the year prior to buprenorphine initiation.

Quantile and Effect β(ΔMeanDailyMMEMonth) Std. Error Pr(>|t|) Quantile andEffect β(ΔMeanDailyMMEMonth) Std. Error Pr(>|t|)
0.25 0.75
 12–10 Months1 −2.33 0.68 ***  12–10 Months −1.65 0.49 ***
 10–8 Months 1.33 0.33 ***  10–8 Months 0.33 0.26
 8–6 Months −0.67 0.32 *  8–6 Months −1.01 0.35 ***
 6–4 Months −1.00 0.45 *  6–4 Months −0.15 0.20
 4–2 Months −2.26 0.54 ***  4–2 Months −0.36 0.22
 2–0 Months −11.24 0.66 ***  2–0 Months −1.61 0.35 ***
0.5 0.9
 12–10 Months 0.00 0.15  12–10 Months −0.65 1.46
 10–8 Months 0.00 0.01  10–8 Months −1.42 0.84 *
 8–6 Months 0.00 0.01  8–6 Months −2.63 0.81 ***
 6–4 Months 0.00 0.00  6–4 Months 0.00 0.67
 4–2 Months −0.50 0.18 **  4–2 Months 0.13 0.65
 2–0 Months −7.03 0.37 ***  2–0 Months −4.05 0.65 ***
*

P<0.05,

**

P<0.01,

***

P<0.001

1

Months prior to buprenorphine induction